Results 81 to 90 of about 5,526 (153)

Carbon Ion Radiotherapy for Unresectable Sacral Chordoma

open access: yes, 2013
Purpose: The results of carbon ion radiotherapy for unresectable sacral chordoma were summarized to evaluate efficacy and safety. Patients and Methods: We performed a retrospective analysis on 175 patients with unresectable sacral chordomas treated with
640539   +11 more
core  

Carbon-ion radiotherapy flourishes in Japan

open access: yes, 2010
More than 500 000 persons are diagnosed with cancer every year in Japan, and it is forecast that this number will continue to rise. In such a situation, the newly-opened GHMC facility, following those at HIMAC and the Hyogo Ion Beam Medical Center, is ...
Noda, Kouji   +3 more
core  

Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report.

open access: yes, 2013
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences.
Kiyohara, Hiroki   +37 more
core   +2 more sources

Analysis of urinary function and prostate volume changes in localized prostate cancer patients treated with carbon-ion radiotherapy; a prospective study

open access: yesRadiation Oncology
Background The potential of carbon ion radiation therapy (CIRT) as a curative treatment for localized prostate cancer (PCa) has garnered attention due to its characteristic dose distribution.
Yoshiyuki Miyazawa   +9 more
doaj   +1 more source

A case of pelvic EWSR1-PATZ1 fusion sarcoma treated with carbon ion radiotherapy

open access: yesRadiology Case Reports
EWSR1-PATZ1 fusion sarcoma is a type of round-cell sarcoma with EWSR1-non-EST fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors.
Toshinari Yagi, MD   +11 more
doaj   +1 more source

Feasibility of carbon-ion radiotherapy for re-irradiation of locoregionally recurrent, metastatic, or secondary lung tumors.

open access: yes, 2018
Intrathoracic recurrence after carbon-ion radiotherapy for primary or metastatic lung tumors remains a major cause of cancer-related deaths. However, treatment options are limited.
Nakajima, Mio   +18 more
core   +1 more source

Current status and future perspective of carbon-ion radiotherapy

open access: yes, 2019
Radiation therapy for cancer by using heavy ions has attracted considerable attention. The accelerated heavy ions can deliver a high dose to a tumor while sparing surrounding normal tissue from undesired exposure because of their superior dose ...
841811, 841810, Inaniwa, Taku
core  

Carbon Ion Radiotherapy in Bone and Soft Tssue Sarcomas

open access: yes, 2010
The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world first heavy ion accelerator complex dedicated to medical use in a hospital environment.
Imaizumi, Takeshi   +27 more
core  

Carbon Ion Radiotherapy for Unresectable Osteosarcoma of the Trunk

open access: yes, 2016
Osteosarcoma is a radioresistant tumor. There have been few reports on the effectiveness of radiotherapy for unresectable osteosarcoma using photo (X-ray) beams.
585929   +7 more
core  

Carbon Ion Radiotherapy for Bone and Soft Tissue sarcomas.

open access: yes, 2013
A clinical trial was first initiated in 1996 to evaluate the safety and efficacy of carbon ion radiotherapy for bone and soft tissue sarcomas not suitable for surgery. As of March 2013, over 900 patients were enrolled in the clinical trials.
今井 礼子   +3 more
core  

Home - About - Disclaimer - Privacy